Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients.
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients. Haematologica. 2022 Dec 01; 107(12):2783-2793.